Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021181261 - LACTOFERRIN FOR ORAL INHALATION USE FOR THE TREATMENT OF A DISEASE CAUSED BY A SARS-CORONA VIRUS

Publication Number WO/2021/181261
Publication Date 16.09.2021
International Application No. PCT/IB2021/051941
International Filing Date 09.03.2021
IPC
A61K 38/40 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
40Transferrins, e.g. lactoferrins, ovotransferrins
A61K 31/198 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19Carboxylic acids, e.g. valproic acid
195having an amino group
197the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid
198Alpha-amino acids, e.g. alanine, edetic acid (EDTA)
A61K 9/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
A61M 15/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
15Inhalators
A61P 31/12 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
CPC
A61K 31/198
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
19Carboxylic acids, e.g. valproic acid
195having an amino group
197the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
198Alpha-aminoacids, e.g. alanine, edetic acids [EDTA],
A61K 31/728
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
726Glycosaminoglycans, i.e. mucopolysaccharides
728Hyaluronic acid
A61K 38/40
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
40Transferrins, e.g. lactoferrins, ovotransferrins
A61K 47/26
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K 47/36
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K 9/0075
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
007Pulmonary tract; Aromatherapy
0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy;
0075for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Applicants
  • SOFAR S.P.A. [IT]/[IT]
Inventors
  • BIFFI, Andrea
  • FIORE, Walter
Agents
  • HOFFMANN EITLE S.R.L.
  • ZANGS, Rainer E.
  • KINDLER, Matthias
  • FRANK, Veit Peter
  • POLZ, Leo
  • STEIN-DRÄGER, Christiane
  • AVERY, Stephen John
  • LETHEM, David James
  • MARSH, Roy David
  • MITCHELL, Alan
  • FURLONG, Christopher Heinrich
  • BAUSCH, Thorsten
  • TAORMINO, Joseph Paul
  • KLUSMANN, Peter
  • SCHWEIGHART, Peter
  • WOLF, Matthias
  • SIEGERT, Georg
  • MAYRHOFER, Stefan
  • STRATMANN, Klemens
  • WIEDEMANN, Peter
  • VON KUROWSKI, Lorenz
  • BECHER, Claus Thomas
  • SPILGIES, Jan-Hendrik
  • RENKEN, Joachim
  • ENGELHARD, Elisabeth
  • BACHELIN, Karl Martin Raimund
  • DISSER, Stephan
  • VAN BOUWELEN, Franciscus Maria
  • FÜCHSLE, Kathrin
  • CIESLA, Ulrike
  • SCHÖN, Anne Katrin
  • VOCKE, Henrik
  • GÖRG, Andreas
  • GARBERG, Morten
  • RUSSELL, John Alistair
  • SPROSTON, David
  • THIRLWELL, Karen
  • SCHEIBLE, Dominik
  • VOS, Bianca-Lucia
  • DOUXCHAMPS, Nicolas
  • STEFFERL, Andreas
  • GOLLER, Daniel
  • PRUSS, Timo
  • WERNER-JONES, Leonard L.
  • BACCELLI, Michele
  • MÜLLER, Markus Georg
  • MUNCKE, Nadja
  • CORNEO, Giovanni
  • STREGE, Christine
  • DRAGOSAVAC, Marko
  • BIRKETT, Matthew
  • ZILLIES, Jan Carl
  • GROHS, Daniel
  • MULHERN, Declan
  • GRIMM, Stephan
  • TILLMANN, Volker
  • OGLE, James Matthew
  • GLAS, Johannes Dominik
  • STEINMÜLLER, Stephan
  • BENEDETTO, Marco
  • LEVINE, Benjamin
  • JONES, Mark A. G.
  • GRAEBER, Jens
  • FUSTER, Gustavo
  • ESSER, Axel T.
  • SCHIEREN, Roland
  • RECKENTHÄLER, Peter
  • CATANIA, Olivier
  • DÖRFEL, Katrin
  • WEINMANN, Lasse
  • SASSE, Stefan
  • MACHOTTA, Axel
  • SCHREIBER, Christian
  • WYDER, Thomas
  • WEIGEL-KRUSEMARCK, Michaela
  • MÜLLER, Michael
  • LEWIS, Debra Louise
  • PAETZOLD, Helge
  • SPIRKOSKA, Danche
Priority Data
10202000000502609.03.2020IT
Publication Language English (en)
Filing Language Italian (IT)
Designated States
Title
(EN) LACTOFERRIN FOR ORAL INHALATION USE FOR THE TREATMENT OF A DISEASE CAUSED BY A SARS-CORONA VIRUS
(FR) LACTOFERRINE POUR UNE UTILISATION PAR INHALATION ORALE POUR LE TRAITEMENT D'UNE MALADIE PROVOQUÉE PAR UN CORONAVIRUS SARS
Abstract
(EN) The present invention relates to a composition comprising lactoferrin for inhalation use in the treatment of viral infections of the respiratory system, and related symptoms or disorders, caused by a SARS- coronavirus (e.g. COVID-19 disease). In addition, the present invention relates to a device for the administration - through the inhalation route - of said composition comprising lactoferrin and the use thereof in said methods for the treatment of viral infections.
(FR) La présente invention concerne une composition comprenant de la lactoferrine pour une utilisation par inhalation dans le traitement d'infections virales du système respiratoire, et de symptômes ou troubles associés, provoqués par un coronavirus SRAS (par ex., le COVID-19) De plus, la présente invention concerne un dispositif pour l'administration par voie pulmonaire de ladite composition comprenant de la lactoferrine et son utilisation dans lesdits procédés pour le traitement d'infections virales.
Latest bibliographic data on file with the International Bureau